Confusing Maalox product to be renamed

A new Maalox product could potentially confuse consumers and, if misused, result in serious side effects, the FDA warned.

Maalox Total Relief is an upset stomach reliever and anti-diarrheal medication, unlike other over-the-counter Maalox products, which are antacids. Bismuth subsalicylate, the active ingredient in Maalox Total Relief, is not appropriate for individuals with a history of gastrointestinal ulcer disease or a bleeding disorder or individuals who are taking certain medications, including oral antidiabetic drugs, anticoagulants, non-steroidal anti-inflammatory drugs and other anti-inflammatory drugs, an FDA press release said.

The manufacturer has agreed to change the name and packaging of Maalox Total Relief, with the new product expected to be available in September 2010. In the meantime, the company will conduct an educational outreach program and monitor adverse events related to the medication.